Cargando…

Overcoming mutation-based resistance to antiandrogens with rational drug design

The second-generation antiandrogen enzalutamide was recently approved for patients with castration-resistant prostate cancer. Despite its success, the duration of response is often limited. For previous antiandrogens, one mechanism of resistance is mutation of the androgen receptor (AR). To prospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balbas, Minna D, Evans, Michael J, Hosfield, David J, Wongvipat, John, Arora, Vivek K, Watson, Philip A, Chen, Yu, Greene, Geoffrey L, Shen, Yang, Sawyers, Charles L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2013
Materias:	Human Biology and Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622181/ https://www.ncbi.nlm.nih.gov/pubmed/23580326 http://dx.doi.org/10.7554/eLife.00499

Ejemplares similares

GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019)

Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
por: Shah, Neel, et al.
Publicado: (2017)

Designer antiandrogens join the race against drug resistance
por: Josan, Jatinder S, et al.
Publicado: (2013)

Rational Second-Generation Antiandrogen Use in Prostate Cancer
por: Orme, Jacob J, et al.
Publicado: (2022)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023)

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
por: Zhang, Zeda, et al.
Publicado: (2020)

Annotating MYC oncogene status with (89)Zr-transferrin imaging
por: Holland, Jason P., et al.
Publicado: (2012)

Overcoming doubt in vaccinations. The end justifies the means?
por: Ciliberti, Rosella, et al.
Publicado: (2022)

The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells
por: Fanning, Sean W, et al.
Publicado: (2018)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

What silent mutations say about the human airways
por: Donne, Matthew L, et al.
Publicado: (2013)

Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis
por: Hieronymus, Haley, et al.
Publicado: (2017)

A Cryptochrome 2 mutation yields advanced sleep phase in humans
por: Hirano, Arisa, et al.
Publicado: (2016)

Applying (89)Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
por: Doran, Michael G., et al.
Publicado: (2016)

Mutation in ATG5 reduces autophagy and leads to ataxia with developmental delay
por: Kim, Myungjin, et al.
Publicado: (2016)

Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
por: Maitland, Norman J.
Publicado: (2021)

Folding mutations suppress early beta-cell proliferation
por: Modi, Honey, et al.
Publicado: (2018)

Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
por: Tian, Xiaohong, et al.
Publicado: (2015)

Advantage of soybean isoflavone as antiandrogen on acne vulgaris
por: Riyanto, Puguh, et al.
Publicado: (2015)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

Challenges in validating candidate therapeutic targets in cancer
por: Settleman, Jeffrey, et al.
Publicado: (2018)

An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish
por: Zou, Jun, et al.
Publicado: (2015)

Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers
por: Sharma, Vidhu, et al.
Publicado: (2016)

Physicochemical Profile of Antiandrogen Drug Bicalutamide: Solubility, Distribution, Permeability
por: Volkova, Tatyana V., et al.
Publicado: (2022)

Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma
por: Unni, Arun M, et al.
Publicado: (2015)

Registered report: IDH mutation impairs histone demethylation and results in a block to cell differentiation
por: Richarson, Adam D, et al.
Publicado: (2016)

Concentration-dependent mortality of chloroquine in overdose
por: Watson, James A, et al.
Publicado: (2020)

Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation
por: Hartmann, Bianca, et al.
Publicado: (2016)

A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency
por: Fouquet, Baptiste, et al.
Publicado: (2017)

Antiandrogenic treatment of obsessive compulsive neurosis: A case review
por: Huerga García, L., et al.
Publicado: (2023)

Corrigendum: Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
por: Tian, Xiaohong, et al.
Publicado: (2015)

Reversing resistance to antiandrogens with a histone deacetylase inhibitor
por: Ferrari, Anna C.
Publicado: (2018)

Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
por: Giotis, Efstathios S., et al.
Publicado: (2022)

A homozygous loss-of-function CAMK2A mutation causes growth delay, frequent seizures and severe intellectual disability
por: Chia, Poh Hui, et al.
Publicado: (2018)

Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice
por: Heckman, Laura Dean, et al.
Publicado: (2014)

Androgens and environmental antiandrogens affect reproductive development and play behavior in the Sprague-Dawley rat.
por: Hotchkiss, A K, et al.
Publicado: (2002)

Evaluating steroid hormone receptor interactions using the live-cell NanoBRET proximity assay
por: Huggins, Rosemary J, et al.
Publicado: (2023)

Marigolds in the CT scanner
por: Hayter, Charles
Publicado: (2021)

Non-invasive imaging of CSF-mediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRI
por: Harrison, Ian F, et al.
Publicado: (2018)

Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
por: Chandran, Vijayendran, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_59emh9taocrcf28dkhfltja3k1